Calidi Biotherapeutics CLDI
NYSE CLDI
$0.64 -0.13 (-16.52%)
As of: Oct 22, 2026 · 3:59 PM EDT

Calidi Biotherapeutics (CLDI) Long-Term Debt Issuances (2022 - 2024)

Updated

Calidi Biotherapeutics' Long-Term Debt Issuances came in at $3 million for FY2024, up 140.0% from $1.25 million in FY2023.

Analysis

Calidi Biotherapeutics (CLDI) Long-Term Debt Issuances (2022 - 2024) Analysis & Trends

Going back to FY2021, Calidi Biotherapeutics' Long-Term Debt Issuances data covers 4 years.

  • Long-Term Debt Issuances carries a three-year compound annual growth rate of 151.4% (FY2021 to FY2024).
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $1.25 million in FY2023 (-51.0%), $2.55 million in FY2022 and $188,804 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Calidi Biotherapeutics 907,797.59 -24.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 600,000.00
Mar 31, 2024 3.20 Mn
Jun 30, 2023 500,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 650,000.00
Sep 30, 2022 2.40 Mn
API Access

Calidi Biotherapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CLDI&period=max&api_key=YOUR_API_KEY